Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European Perspective.
AF
Anticoagulants
antiplatelet agents
antithrombotic therapy
coronary artery disease
percutaneous coronary intervention
Journal
Interventional cardiology (London, England)
ISSN: 1756-1485
Titre abrégé: Interv Cardiol
Pays: England
ID NLM: 101559687
Informations de publication
Date de publication:
2023
2023
Historique:
received:
19
10
2021
accepted:
20
03
2022
medline:
21
8
2023
pubmed:
21
8
2023
entrez:
21
8
2023
Statut:
epublish
Résumé
AF is a highly prevalent disease, often requiring long-term oral anticoagulation to prevent stroke or systemic embolism. Coronary artery disease, which is common among AF patients, is often referred for myocardial revascularisation by percutaneous coronary intervention (PCI), which requires dual antiplatelet therapy to minimise the risk of stent-related complications. The overlap of AF and PCI is a clinical conundrum, especially in the early post-procedural period, when both long-term oral anticoagulation and dual antiplatelet therapy are theoretically indicated as a triple antithrombotic therapy. However, stacking drugs is not a desirable option because of the increased bleeding risk. Several strategies have been investigated to mitigate this concern, including shortening triple antithrombotic therapy duration and switching to a dual antithrombotic regimen. This review analyses the mechanisms underlying thrombotic complications in AF-PCI, summarises evidence surrounding antithrombotic therapy regimens and reports and comments on the latest European guidelines.
Identifiants
pubmed: 37601736
doi: 10.15420/icr.2021.30
pmc: PMC10433110
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e05Informations de copyright
Copyright © The Author(s), 2023. Published by Radcliffe Group Ltd.
Déclaration de conflit d'intérêts
Disclosure: DC received advisory or lecture fees from Amgen, Daiichi Sankyo and Sanofi. All other authors have no conflicts of interest to declare.
Références
Circulation. 2021 Oct 12;144(15):1196-1211
pubmed: 34455849
Circulation. 2019 Jan 29;139(5):604-616
pubmed: 30586700
J Am Coll Cardiol. 2017 Oct 10;70(15):1846-1857
pubmed: 28982497
Circulation. 2019 Feb 5;139(6):775-786
pubmed: 30586754
Lancet. 2007 Aug 11;370(9586):493-503
pubmed: 17693178
EuroIntervention. 2020 Jun 12;16(2):e164-e172
pubmed: 32091400
Circulation. 2019 Jul 16;140(3):240-261
pubmed: 31116032
Circulation. 2020 Mar 3;141(9):781-783
pubmed: 31707833
Eur Heart J. 2019 Dec 7;40(46):3757-3767
pubmed: 31651946
Europace. 2019 Feb 1;21(2):192-193
pubmed: 30052888
EuroIntervention. 2021 Dec 03;17(11):e898-e909
pubmed: 34105513
Expert Rev Cardiovasc Ther. 2021 Apr;19(4):301-312
pubmed: 33706641
JACC Cardiovasc Interv. 2019 Dec 9;12(23):2346-2355
pubmed: 31806216
Circulation. 2021 Mar 23;143(12):1215-1223
pubmed: 33461308
Interv Cardiol. 2020 Apr 23;15:e02
pubmed: 32382318
J Am Coll Cardiol. 2013 May 21;61(20):2060-6
pubmed: 23524219
Circulation. 2020 May 19;141(20):1618-1627
pubmed: 32223444
Circulation. 1998 Nov 17;98(20):2126-32
pubmed: 9815866
EuroIntervention. 2021 Aug 27;17(6):474-480
pubmed: 33164896
JAMA Cardiol. 2020 May 1;5(5):582-589
pubmed: 32101251
Europace. 2014 May;16(5):631-8
pubmed: 24158253
Eur Heart J. 2018 May 14;39(19):1726-1735a
pubmed: 29668889
Thromb Haemost. 2022 Mar;122(3):445-455
pubmed: 34638150
JACC Cardiovasc Interv. 2019 Aug 26;12(16):1590-1593
pubmed: 31439339
Eur Heart J. 2019 May 14;40(19):1553-1562
pubmed: 30793734
JAMA Cardiol. 2019 Aug 1;4(8):747-755
pubmed: 31215979
N Engl J Med. 2016 Dec 22;375(25):2423-2434
pubmed: 27959713
Circulation. 1998 Oct 20;98(16):1597-603
pubmed: 9778323
Thromb Haemost. 2018 Oct;118(10):1681-1685
pubmed: 30273951
J Am Heart Assoc. 2020 Aug 18;9(16):e017212
pubmed: 32805186
JACC Cardiovasc Interv. 2019 Aug 26;12(16):1553-1561
pubmed: 31439336
Chest. 2010 Nov;138(5):1093-100
pubmed: 20299623
EuroIntervention. 2021 Feb 19;16(14):1154-1162
pubmed: 32624464
Thromb Haemost. 2019 Jan;119(1):9-13
pubmed: 30597496
J Atr Fibrillation. 2014 Oct 31;7(3):1112
pubmed: 27957114
N Engl J Med. 2011 Mar 3;364(9):806-17
pubmed: 21309657
Circ Cardiovasc Interv. 2019 Nov;12(11):e008307
pubmed: 31707804
Am J Cardiol. 2020 Mar 1;125(5):735-743
pubmed: 31924322
J Am Coll Cardiol. 2014 Oct 7;64(14):1430-6
pubmed: 25277612
J Am Coll Cardiol. 2016 Oct 25;68(17):1851-1864
pubmed: 27595509
Lancet. 2019 Oct 12;394(10206):1335-1343
pubmed: 31492505
Eur Heart J. 2020 Oct 7;41(38):3743-3749
pubmed: 33029615
Eur Heart J. 2020 Dec 14;41(47):4497-4504
pubmed: 32860041
Lancet. 2017 Mar 11;389(10073):1025-1034
pubmed: 28290994
Eur Heart J. 2012 Mar;33(5):606-13
pubmed: 22232428
Lancet. 2006 Jun 10;367(9526):1903-12
pubmed: 16765759
Adv Med Sci. 2018 Mar;63(1):30-35
pubmed: 28818746
JAMA Cardiol. 2021 Apr 1;6(4):410-419
pubmed: 33404627
N Engl J Med. 1996 Apr 25;334(17):1084-9
pubmed: 8598866
Nat Rev Cardiol. 2018 Aug;15(8):480-496
pubmed: 29973709
JACC Cardiovasc Interv. 2021 Aug 23;14(16):1801-1811
pubmed: 34332946
EuroIntervention. 2020 Apr 17;15(17):1548-1554
pubmed: 31845892
Expert Rev Cardiovasc Ther. 2019 Jul;17(7):479-496
pubmed: 31198065
N Engl J Med. 2011 Sep 15;365(11):981-92
pubmed: 21870978
Circulation. 2014 Apr 15;129(15):1577-85
pubmed: 24470482
Clin Res Cardiol. 2013 Nov;102(11):799-806
pubmed: 23771774
N Engl J Med. 1998 Dec 3;339(23):1665-71
pubmed: 9834303
JACC Cardiovasc Interv. 2019 Dec 9;12(23):2331-2341
pubmed: 31806214
Cardiol J. 2020;27(1):8-15
pubmed: 31960945
Eur Heart J. 2021 Feb 1;42(5):373-498
pubmed: 32860505
Eur Heart J. 2021 Apr 7;42(14):1289-1367
pubmed: 32860058
N Engl J Med. 2013 Nov 28;369(22):2093-104
pubmed: 24251359
Europace. 2020 Apr 1;22(4):538-546
pubmed: 31942971
Thromb Haemost. 2018 Jun;118(6):949-952
pubmed: 29847837
N Engl J Med. 2021 Oct 28;385(18):1643-1655
pubmed: 34449185
Circulation. 2018 Mar 20;137(12):e67-e492
pubmed: 29386200
Circ Cardiovasc Interv. 2020 Apr;13(4):e008349
pubmed: 32252548
Int J Cardiol. 2020 Mar 1;302:95-102
pubmed: 31924397
EuroIntervention. 2020 Aug 28;16(5):371-379
pubmed: 32065586
Lancet. 2013 Mar 30;381(9872):1107-15
pubmed: 23415013
N Engl J Med. 2009 May 14;360(20):2066-78
pubmed: 19336502
J Am Coll Cardiol. 2022 Jan 18;79(2):e21-e129
pubmed: 34895950
BMJ. 2006 Nov 25;333(7578):1091
pubmed: 17032691
N Engl J Med. 2017 Oct 19;377(16):1513-1524
pubmed: 28844193
J Am Coll Cardiol. 2020 Jun 2;75(21):2711-2722
pubmed: 32466887
JACC Cardiovasc Interv. 2018 Apr 9;11(7):626-634
pubmed: 29550085
J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2915-2931
pubmed: 30522654
J Am Coll Cardiol. 2009 Apr 21;53(16):1399-409
pubmed: 19371823
N Engl J Med. 2019 Sep 19;381(12):1103-1113
pubmed: 31475793
J Am Coll Cardiol. 2021 Feb 9;77(5):629-658
pubmed: 33250267
Circ Cardiovasc Interv. 2011 Dec 1;4(6):629-37
pubmed: 22186107
Lancet. 2021 Apr 17;397(10283):1470-1483
pubmed: 33865495
N Engl J Med. 2011 Sep 8;365(10):883-91
pubmed: 21830957
Circulation. 2019 Dec 3;140(23):1921-1932
pubmed: 31557056
Lancet. 2021 Jun 26;397(10293):2487-2496
pubmed: 34010616
Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):216-226
pubmed: 33258897
N Engl J Med. 2009 Sep 17;361(12):1139-51
pubmed: 19717844
N Engl J Med. 2019 Apr 18;380(16):1509-1524
pubmed: 30883055
Nat Rev Cardiol. 2022 Feb;19(2):117-132
pubmed: 34426673
EuroIntervention. 2008 Aug;4 Suppl C:C27-32
pubmed: 19202688
Lancet. 2014 Mar 15;383(9921):955-62
pubmed: 24315724
Eur Heart J. 2021 Jan 21;42(4):308-319
pubmed: 33284979
J Am Coll Cardiol. 2015 Apr 28;65(16):1619-1629
pubmed: 25908066
JACC Cardiovasc Interv. 2022 Feb 14;15(3):268-277
pubmed: 35144783